Sarepta started in Corvallis, Oregon on January 1, 1980 and was originally named Antivirals Inc.
The company made headlines in 2003 when it announced work on treatments for severe acute respiratory syndrome (SARS) and the West Nile virus.
In July 2009, the company announced they would move their headquarters from Portland, Oregon, north to Bothell, Washington, near Seattle.
The company lost $19.7 million in the second quarter of 2009, and then won an $11.5 million contract with the United States Department of Defense's Defense Threat Reduction Agency in October 2009.
The Corvallis laboratory facility was closed in 2016.
|Company Name||Founded Date||Revenue||Employee Size||Job Openings|
Zippia gives an in-depth look into the details of Sarepta Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sarepta Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Sarepta Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sarepta Therapeutics. The data presented on this page does not represent the view of Sarepta Therapeutics and its employees or that of Zippia.
Sarepta Therapeutics may also be known as or be related to Sarepta Therapeutics, Sarepta Therapeutics Inc, Sarepta Therapeutics Inc. and Sarepta Therapeutics, Inc.